Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR sell WaltFinance

Start price
13.10.21 / 10%
Target price
Performance (%)
This prediction is currently active. The SELL prediction by WaltFinance shows the price for BioNTech SE ADR has slightly increased by 1.47%. This prediction currently runs until 13.10.24. The prediction end date can be changed by WaltFinance at any time. WaltFinance has 10% into this prediction This prediction was marked as speculative and is excluded from WaltFinance's performance statistics.
Performance without dividends (%)
Name 1w
BioNTech SE ADR 1.47%
iShares Core DAX® 1.657%
iShares Core MSCI World 0.769%
iShares Nasdaq 100 0.811%
iShares S&P 500 0.599%

According to WaltFinance what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
Risky balance sheet
Low dividend yield expected
Little Investments for future growth
Few uniques
Below average Marketposition
Little known brand
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Bad rating
negative Cash Flow expected
ROE lower than 10% per year
Higher risks for its business
Below average Management
Bad culture
Little innovation
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Significant cyclical dependencies
Business model of the past or high risk

Comments by WaltFinance for this prediction

In the thread Biontech SE diskutieren
Prediction Sell
Perf. (%) 1.47%
Target price 130.000
Ends at 13.10.24

Sell mit Kursziel 130,0